Clinical Trials Directory

Trials / Completed

CompletedNCT00597350

Effect of Fenugreek on Blood Sugar and Insulin in Diabetic Humans

Pilot Study of the Effect of Fenugreek on Blood Sugar and Insulin in Diabetic Humans

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if bread containing fenugreek reduces blood sugar and insulin compared to identical bread without fenugreek.

Detailed description

Trigonella foenum-graecum (fenugreek) has been used in traditional medicine for the treatment of diabetes. Fenugreek has been demonstrated to lower blood glucose in response to a glucose load while leaving the levels of serum insulin unaffected in rodents. This effect of lowering blood sugar without changing insulin levels demonstrates improved insulin action. Fenugreek has also been shown to decrease glucose absorption by inhibiting intestinal disaccharidases. Fenugreek decreases glycohemoglobin in diabetic rodents. An amino acid extracted from fenugreek seeds, 4-hydroxyisoleucine, decreases glucose and insulin in diabetic rodents, improves glucose tolerance and stimulates insulin secretion from isolated pancreatic rodent islets. Fenugreek imparts a bitter taste to products into which it is placed, and this property has limited its use in treating diabetes. Dr. Losso and his associates developed a process that allows incorporation of fenugreek into bread and other bakery goods without imparting a bitter taste, and the success of this process was confirmed in taste testing. This study is designed to evaluate the effect of fenugreek bread made by Dr. Losso's proprietary process on glucose and insulin.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTrigonella foenum-graecum (fenugreek)2 slices of bread containing 5 grams of the natural herb fenugreek 2 times, 1 week apart

Timeline

Start date
2007-11-01
Primary completion
2008-01-01
Completion
2008-02-01
First posted
2008-01-18
Last updated
2015-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00597350. Inclusion in this directory is not an endorsement.